Schrodinger (NASDAQ:SDGR) Stock Price Breaks Above 50 Day Moving Average – Time to Sell?

Schrodinger, Inc. (NASDAQ:SDGR)’s share price crossed above its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $24.15 and traded as high as $24.89. Schrodinger shares last traded at $24.50, with a volume of 1,263,582 shares.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on SDGR shares. Zacks Research raised Schrodinger from a “hold” rating to a “strong-buy” rating in a research note on Monday, October 5th. Wall Street Zen raised Schrodinger from a “strong sell” rating to a “hold” rating in a research note on Saturday, August 8th. TD Cowen boosted their price target on shares of Schrodinger from $20.00 to $31.00 and gave the company a “buy” rating in a research report on Tuesday, October 13th. BMO Capital Markets upped their price objective on shares of Schrodinger from $24.00 to $30.00 and gave the company an “outperform” rating in a report on Monday, October 12th. Finally, UBS Group raised their price objective on shares of Schrodinger from $19.00 to $21.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 20th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $25.83.

Schrodinger Trading Up 2.9%

The stock has a market cap of $1.81 billion, a PE ratio of -33.11 and a beta of 1.62. The company has a fifty day moving average of $24.15 and a 200-day moving average of $16.61.

Schrodinger (NASDAQ:SDGR) last announced its earnings results on Wednesday, August 5th. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of ($0.41) by $0.49. Schrodinger had a negative net margin of 20.98% and a negative return on equity of 16.37%. The firm had revenue of $58.89 million for the quarter, compared to the consensus estimate of $47.19 million. During the same period in the prior year, the firm earned ($0.65) EPS. The firm’s revenue for the quarter was up 7.5% on a year-over-year basis. As a group, research analysts anticipate that Schrodinger, Inc. will post -1.50 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, insider Karen Akinsanya sold 31,599 shares of the firm’s stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $29.37, for a total value of $928,062.63. Following the sale, the insider owned 69,956 shares of the company’s stock, valued at $2,054,607.72. This trade represents a 31.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.10% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Rubric Capital Management LP increased its position in shares of Schrodinger by 43.8% in the 1st quarter. Rubric Capital Management LP now owns 6,000,000 shares of the company’s stock valued at $68,160,000 after purchasing an additional 1,828,502 shares during the last quarter. Quantinno Capital Management LP acquired a new stake in shares of Schrodinger in the 1st quarter valued at $1,978,000. Tejara Capital Ltd purchased a new stake in shares of Schrodinger during the 2nd quarter worth $4,553,000. BlackRock Inc. purchased a new stake in shares of Schrodinger during the 2nd quarter worth $170,978,000. Finally, Bank of America Corp DE purchased a new stake in shares of Schrodinger during the 2nd quarter worth $2,936,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Schrodinger Company Profile

Schrödinger, Inc develops computational software and services designed to support pharmaceutical, biotechnology and materials research. Its platform uses physics-based modeling, machine learning and other computational methods to help scientists analyze molecular interactions, design compounds and prioritize candidates for experimental testing.

The company’s software offerings include tools for molecular modeling, quantum chemistry, molecular dynamics, virtual screening, property prediction and free-energy calculations.